Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study
Critically ill patients with coronavirus diseases 2019 (COVID-19) are of grave concern. Those patients usually underwent a stage of excessive inflammation before developing acute respiratory distress syndrome. In this study, we test the hypothesis that short-term, low-to-moderate-dose corticosteroid...
Saved in:
| Main Authors: | Yang Li, Xian Zhou, Tao Li, Shiji Chan, Yiqi Yu, Jing-Wen Ai, Haocheng Zhang, Feng Sun, Qiran Zhang, Lei Zhu, Lingyun Shao, Bin Xu, Wenhong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-01-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1807885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corticosteroid-Induced Psychiatric Disorders: Mechanisms, Outcomes, and Clinical Implications
by: Lara Nasereddin, et al.
Published: (2024-11-01) -
The subtle nuances of intranasal corticosteroids
by: James Fowler, et al.
Published: (2021-03-01) -
Local Corticosteroids for Alopecia Areata: A Narrative Review
by: Samantha Gregoire, et al.
Published: (2025-05-01) -
The corticosteroid dose-response curve in asthma and how to identify patients for adjunctive and alternate therapies
by: E.M. Irusen
Published: (2006-03-01) -
Corticosteroid phobia among parents of asthmatic children
by: Deniz Özçeker, et al.
Published: (2018-04-01)